Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Therapeutic-area index

Type 2 diabetesPeptide Trials.

Explore peptide clinical trials tagged to the type 2 diabetes condition group in the current local registry snapshot. Condition groups are PeptideStat search classifications layered over source-reported indications.

Studies
200
Recruiting
26
Completed
119
Results posted
58
Countries
61
Avg enrollment
567

Velocity

Type 2 diabetes trials by start year

Study start year · indexed snapshot

2821147020022002: 1 trials2003: 1 trials2004: 0 trials2005: 2 trials2006: 1 trials20072007: 2 trials2008: 2 trials2009: 6 trials2010: 4 trials2011: 2 trials20122012: 6 trials2013: 7 trials2014: 9 trials2015: 5 trials2016: 12 trials20172017: 8 trials2018: 12 trials2019: 8 trials2020: 7 trials2021: 9 trials20222022: 12 trials2023: 14 trials2024: 28 trials2025: 20 trials20262026: 22 trials

Development

Trials by phase

Early Phase 11
Phase 122
Phase 236
Phase 371
Phase 436

Industry

Leading sponsors

Sanofi37
Eli Lilly19
AstraZeneca11
GlaxoSmithKline9
MedImmune LLC9
Novo Nordisk9
Amgen6
Innovent Biologics (Suzhou) Co. Ltd.5

Therapeutic areas

Condition groups

Type 2 diabetes200
Weight loss39
Brain health2
Inflammation2
Longevity1
Muscle growth1

Compound leaders

Most represented peptides.

01Lixisenatide4502Dulaglutide3603Semaglutide2104Exenatide2005Liraglutide1706Cotadutide1407Albiglutide1208Glucagon1009Cagrilintide810Mazdutide811Pramlintide812Maridebart cafraglutide6

Study explorer

Search this collection.

200 matching studies